Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023

BUY
$2.33 - $5.07 $12,582 - $27,378
5,400 Added 2.46%
225,000 $535,000
Q2 2023

Aug 09, 2023

BUY
$4.67 - $6.55 $21,015 - $29,475
4,500 Added 2.09%
219,600 $1.05 Million
Q1 2023

May 10, 2023

SELL
$4.95 - $6.09 $121,770 - $149,814
-24,600 Reduced 10.26%
215,100 $1.22 Million
Q4 2022

Feb 08, 2023

BUY
$5.09 - $9.05 $35,121 - $62,445
6,900 Added 2.96%
239,700 $1.34 Million
Q3 2022

Nov 09, 2022

BUY
$3.5 - $7.2 $284,900 - $586,080
81,400 Added 53.76%
232,800 $1.5 Million
Q2 2022

Aug 09, 2022

SELL
$2.7 - $7.62 $31,050 - $87,630
-11,500 Reduced 7.06%
151,400 $519,000
Q1 2022

May 09, 2022

BUY
$6.3 - $8.84 $76,230 - $106,964
12,100 Added 8.02%
162,900 $1.16 Million
Q2 2021

Aug 06, 2021

BUY
$18.46 - $24.36 $90,454 - $119,364
4,900 Added 3.36%
150,800 $3.6 Million
Q1 2021

May 07, 2021

BUY
$17.66 - $28.92 $125,386 - $205,332
7,100 Added 5.12%
145,900 $3 Million
Q4 2020

Feb 05, 2021

BUY
$23.25 - $37.73 $3.23 Million - $5.24 Million
138,800 New
138,800 $3.4 Million
Q2 2019

Aug 02, 2019

SELL
$2.28 - $7.35 $82,308 - $265,335
-36,100 Closed
0 $0
Q4 2018

Feb 13, 2019

BUY
$4.52 - $8.88 $11,299 - $22,200
2,500 Added 7.44%
36,100 $163,000
Q3 2017

Nov 03, 2017

BUY
$12.81 - $16.85 $430,416 - $566,160
33,600
33,600 $539,000

Others Institutions Holding MCRB

About Seres Therapeutics, Inc.


  • Ticker MCRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,072,000
  • Market Cap $104M
  • Description
  • Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...
More about MCRB
Track This Portfolio

Track Swiss National Bank Portfolio

Follow Swiss National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.